Novartis
Current and novel options in CML therapy - how to optimize treatment
outcomes of chronic myeloid leukemia without compromises?

Abbvie
Let`s discuss lymphoid malignancies: An interactive symposium on therapy
management in Swiss clinical practice in CLL and DLBCL

Pfizer
Clever Together - Moving forward in metastatic disease

Astellas
Exploring a new treatment option for nmHSPC patients with high risk BCR

Eli Lilly
Targeting HR+HER2- high-risk breast cancer: Latest Data & Real-World Evidence

GSK
Myelofibrosis in Routine Clinical Practice: How do I manage patients?'

AstraZeneca
Navigating the complexity of cancer treatment: the opportunity of
shared-decision making in light of the evolving treatment landscape

 Johnson & Johnson
Transforming Paradigms: Embracing a New Era in the Treatment
of Multiple Myeloma

Servier
Recent advances and future directions of IDH mutant inhibition in cancer therapy